GLG receives GRAS no objection letter for stevia sweeteners

June 6, 2014

GLG Life Tech Corp. has announced that the U.S. Food and Drug Administration (FDA) has issued a Generally Recognized as Safe (GRAS) letter of no objection covering several of GLG’s high-purity stevia extracts. These extracts, each containing over 95% steviol glycosides (predominantly rebaudioside A and stevioside), include GLG’s Rebsweet and AnySweetPLUS stevia extract products (with rebaudioside A content ranging from 50% to 85%).

To date, GLG has received five GRAS letters of no objection covering an array of high-purity stevia products, with a sixth GRAS determination pending FDA review (for high-purity rebaudioside M) and two other GRAS projects currently underway (for high-purity rebaudioside C and D).

Press release (pdf)